Increased Expression of Matrix Metalloproteinases (MMP)-2, MMP-9, and the Urokinase-Type Plasminogen Activator Is Associated with Progression from Benign to Advanced Ovarian Cancer
SCHMALFELDT, Barbara, PRECHTEL, Dieter, LENGYEL, Ernst, HURTING, Kathrin, SPÄTHE, Kerstin, RUTKE, Stefan, KONIK, Elisabeth, FRIDMAN, Rafael, BERGER, Ursula, SCHMITT, Manfred, KUHN, Walther
Published in Clinical cancer research (01.08.2001)
Get full text
Published in Clinical cancer research (01.08.2001)
Journal Article
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma
Kuhn, Walther, Rutke, Stefan, Späthe, Kerstin, Schmalfeldt, Barbara, Florack, Gerd, von Hundelshausen, Burkhardt, Pachyn, Dmytro, Ulm, Kurt, Graeff, Henner
Published in Cancer (15.11.2001)
Published in Cancer (15.11.2001)
Get full text
Journal Article
Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group
Hilpert, F, Stähle, A, Tomé, O, Burges, A, Rossner, D, Späthe, K, Heilmann, V, Richter, B, du Bois, A
Published in Supportive care in cancer (01.10.2005)
Published in Supportive care in cancer (01.10.2005)
Get full text
Journal Article
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
KUHN, W, SCHMALFELDT, B, JÄNICKE, F, SCHMITT, M, GRAEFF, H, REUNING, U, PACHE, L, BERGER, U, ULM, K, HARBECK, N, SPÄTHE, K, DETTMAR, P, HÖFLER, H
Published in British Journal of Cancer (01.04.1999)
Published in British Journal of Cancer (01.04.1999)
Get full text
Journal Article
Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian Cancer
Lengyel, Ernst, Schmalfeldt, Barbara, Konik, Elisabeth, Späthe, Kerstin, Härting, Kathrin, Fenn, Anke, Berger, Ursula, Fridman, Rafael, Schmitt, Manfred, Prechtel, Dieter, Kuhn, Walther
Published in Gynecologic oncology (01.08.2001)
Published in Gynecologic oncology (01.08.2001)
Get full text
Journal Article
Disease-adapted relapse therapy for ovarian cancer: results of a prospective study
Kuhn, W, Schmalfeldt, B, Pache, L, Späthe, K, Ulm, K, Renziehausen, K, Nöschel, H, Canzler, E, Richter, B, Kroner, M, Tilch, G, Janicke, F, Graeff, H
Published in International journal of oncology (01.07.1998)
Published in International journal of oncology (01.07.1998)
Get more information
Journal Article
NEUROPROTECTION WITH AMIFOSTINE IN THE 1ST-LINE TREATMENT OF ADVANCED OVARIAN CANCER WITH CARBOPLATIN/TAXANE-BASED CHEMOTHERAPY – A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE II-STUDY FROM THE AGO OVARIAN CANCER STUDY GROUP
Belau, A. K., Hilpert, F., Stahle, A., Tome, O., Burges, A., Rossner, D., Spathe, K., Heilmann, V., Richter, B., du Bois, A.
Published in International journal of gynecological cancer (01.09.2004)
Published in International journal of gynecological cancer (01.09.2004)
Get full text
Journal Article
38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group
Wimberger, P., Kimmig, R., Hilpert, F., Stähle, A., Burges, A., Tomé, O., Rossner, D., Späthe, K., Heilmann, V., du Bois, A.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article